Novaliq GmbH

Company Drug

Jiangsu Hengrui Announces NMPA Approval for Miebo in Dry Eye Disease Treatment

Fineline Cube Jul 4, 2025

China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received marketing approval...

Company Drug

Hengrui Pharmaceuticals’ SHR8028 Receives NMPA Review for Dry Eye Treatment

Fineline Cube Mar 21, 2023

China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced that a market approval filing...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod